首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations
【24h】

Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations

机译:结核分枝杆菌麦芽糖基转移酶抑制剂的结构见解:基于药效团的虚拟筛选,对接和分子动力学模拟

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pharmacophore-based virtual screening, subsequent docking, and molecular dynamics (MD) simulations have been done to identify potential inhibitors of maltosyl transferase of Mycobacterium tuberculosis (mtb GlgE). Ligand and structure-based pharmacophore models representing its primary binding site (pbs) and unique secondary binding site 2 (sbs2), respectively, were constructed based on the three dimensional structure of mtb GlgE. These pharmacophore models were further used for screening of ZINC and antituberculosis compounds database (ATD). Virtually screened molecules satisfying Lipinski's rule of five were then analyzed using docking studies and have identified 23 molecules with better binding affinity than its natural substrate, maltose. Four top scoring ligands from ZINC and ATD that either binds to pbs or sbs2 have been subjected to 10ns each MD simulations and binding free energy calculations. Results of these studies have confirmed stable protein ligand binding. Results reported in the article are likely to be helpful in antitubercular therapeutic development research.
机译:已经完成了基于药理学的虚拟筛选,对接和分子动力学(MD)模拟,以鉴定结核分枝杆菌(mtb GlgE)的麦芽糖基转移酶的潜在抑制剂。基于mtb GlgE的三维结构,分别构建了分别表示其主要结合位点(pbs)和独特的次级结合位点2(sbs2)的配体和基于结构的药效团模型。这些药效团模型进一步用于ZINC和抗结核化合物数据库(ATD)的筛选。然后,通过对接研究分析了满足Lipinski规则的五个分子的虚拟筛选分子,并鉴定出23种分子的亲和力比其天然底物麦芽糖更好。 ZINC和ATD的四个与pbs或sbs2结合的得分最高的配体已分别进行了10ns的MD模拟和结合自由能计算。这些研究的结果证实了稳定的蛋白质配体结合。文章中报道的结果可能有助于抗结核治疗的发展研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号